"CHO Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells.
| Descriptor ID |
D016466
|
| MeSH Number(s) |
A11.251.210.200 A11.436.155
|
| Concept/Terms |
CHO Cells- CHO Cells
- CHO Cell
- Cell, CHO
- Cells, CHO
|
Below are MeSH descriptors whose meaning is more general than "CHO Cells".
Below are MeSH descriptors whose meaning is more specific than "CHO Cells".
This graph shows the total number of publications written about "CHO Cells" by people in this website by year, and whether "CHO Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 6 | 6 |
| 2001 | 0 | 7 | 7 |
| 2002 | 0 | 7 | 7 |
| 2003 | 0 | 17 | 17 |
| 2004 | 0 | 6 | 6 |
| 2005 | 0 | 5 | 5 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 5 | 5 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 6 | 6 |
| 2012 | 0 | 5 | 5 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 4 | 4 |
| 2015 | 0 | 4 | 4 |
| 2016 | 0 | 4 | 4 |
| 2018 | 0 | 4 | 4 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "CHO Cells" by people in Profiles.
-
Functional and pharmacological investigation of novel and de novo KCND3 variants identified in patients with neurodevelopmental disorders. J Hum Genet. 2026 Apr; 71(4):187-193.
-
Characteristic profiling of CHO-cell expressed MERS-CoV RBD-Fc. Int J Biol Macromol. 2025 Jun; 311(Pt 2):143678.
-
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology. Biochem Pharmacol. 2024 09; 227:116401.
-
Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment. Neurotherapeutics. 2024 Jan; 21(1):e00296.
-
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell. 2021 04 01; 184(7):1804-1820.e16.
-
Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3. Nat Chem Biol. 2020 03; 16(3):351-360.
-
Single-Atom Fluorescence Switch: A General Approach toward Visible-Light-Activated Dyes for Biological Imaging. J Am Chem Soc. 2019 09 18; 141(37):14699-14706.
-
SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals. Hum Mutat. 2019 07; 40(7):908-925.
-
Identification of an XRCC1 DNA binding activity essential for retention at sites of DNA damage. Sci Rep. 2019 02 28; 9(1):3095.
-
Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites. Mol Pharmacol. 2018 10; 94(4):1197-1209.